Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study release_nw2l7uivsjcjpj5xpbzm7zlpm4

by Samantha L. Gardener, Stephanie R. Rainey-Smith, Victor L. Villemagne, Jurgen Fripp, Vincent Doré, Pierrick Bourgeat, Kevin Taddei, Christopher Fowler, Colin L. Masters, Paul Maruff, Christopher C. Rowe, David Ames (+2 others)

Published in Frontiers in Aging Neuroscience by Frontiers Media SA.

2021   Volume 13, p744872

Abstract

<jats:bold>Background:</jats:bold> Worldwide, coffee is one of the most popular beverages consumed. Several studies have suggested a protective role of coffee, including reduced risk of Alzheimer's disease (AD). However, there is limited longitudinal data from cohorts of older adults reporting associations of coffee intake with cognitive decline, in distinct domains, and investigating the neuropathological mechanisms underpinning any such associations.<jats:bold>Methods:</jats:bold> The aim of the current study was to investigate the relationship between self-reported habitual coffee intake, and cognitive decline assessed using a comprehensive neuropsychological battery in 227 cognitively normal older adults from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) study, over 126 months. In a subset of individuals, we also investigated the relationship between habitual coffee intake and cerebral Aβ-amyloid accumulation (<jats:italic>n</jats:italic> = 60) and brain volumes (<jats:italic>n</jats:italic> = 51) over 126 months.<jats:bold>Results:</jats:bold> Higher baseline coffee consumption was associated with slower cognitive decline in executive function, attention, and the AIBL Preclinical AD Cognitive Composite (PACC; shown reliably to measure the first signs of cognitive decline in at-risk cognitively normal populations), and lower likelihood of transitioning to mild cognitive impairment or AD status, over 126 months. Higher baseline coffee consumption was also associated with slower Aβ-amyloid accumulation over 126 months, and lower risk of progressing to "moderate," "high," or "very high" Aβ-amyloid burden status over the same time-period. There were no associations between coffee intake and atrophy in total gray matter, white matter, or hippocampal volume.<jats:bold>Discussion:</jats:bold> Our results further support the hypothesis that coffee intake may be a protective factor against AD, with increased coffee consumption potentially reducing cognitive decline by slowing cerebral Aβ-amyloid accumulation, and thus attenuating the associated neurotoxicity from Aβ-amyloid-mediated oxidative stress and inflammatory processes. Further investigation is required to evaluate whether coffee intake could be incorporated as a modifiable lifestyle factor aimed at delaying AD onset.
In application/xml+jats format

Archived Files and Locations

application/pdf  414.3 kB
file_6ezlh5viofcbrhjksml23l3lxu
fjfsdata01prod.blob.core.windows.net (publisher)
web.archive.org (webarchive)
application/pdf  457.4 kB
file_zjhzysu2drg25jpwse6eojtccy
ro.ecu.edu.au (web)
web.archive.org (webarchive)
application/pdf  352.3 kB
file_gpm3aetqhrfwpaebppltt4mbjy
researchrepository.murdoch.edu.au (web)
web.archive.org (webarchive)
application/pdf  497.5 kB
file_d4durh2wknejzku6c6ysh3ovfu
rest.neptune-prod.its.unimelb.edu.au (web)
web.archive.org (webarchive)

Web Captures

https://www.frontiersin.org/articles/10.3389/fnagi.2021.744872/full
2022-06-23 21:10:52 | 34 resources
webcapture_5jojpoxe6re6pifocmion57g3q
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2021-11-19
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  1663-4365
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: bb5f843c-2fd5-4c8f-8ff8-1bee651bff0b
API URL: JSON